UBS Group’s AllianzIM U.S. Equity Buffer10 Feb ETF FEBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-187
Closed -$7K 10621
2026
Q1
$7K Buy
187
+7
+4% +$269 ﹤0.01% 8635
2025
Q4
$6.86K Sell
180
-4,211
-96% -$158K ﹤0.01% 8500
2025
Q3
$163K Buy
+4,391
New +$158K ﹤0.01% 6794
2025
Q1
Sell
-410
Closed -$13.9K 10363
2024
Q4
$13.9K Buy
410
+389
+1,852% +$13K ﹤0.01% 8118
2024
Q3
$692 Sell
21
-548
-96% -$17.7K ﹤0.01% 8845
2024
Q2
$18.2K Buy
+569
New +$17.7K ﹤0.01% 7357
2024
Q1
Sell
-347
Closed -$10K 9516
2023
Q4
$10K Buy
+347
New +$9.45K ﹤0.01% 7457
2023
Q3
Sell
-2,015
Closed -$54.3K 9608
2023
Q2
$54.3K Buy
+2,015
New +$52K ﹤0.01% 6423

Other funds holding FEBT

UBS Group's FEBT Position: Q2 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer10 Feb ETF (FEBT) in Q2 2026, closing a stake of 187 shares — an estimated $7K sold.

UBS Group first reported a position in FEBT in Q2 2023 and held it in 8 quarters. The position peaked at $163K in Q3 2025. 54 funds tracked by Wall St. Rank hold FEBT as of Q2 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer10 Feb ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 187 AllianzIM U.S. Equity Buffer10 Feb ETF shares in Q2 2026, an estimated $7K.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer10 Feb ETF in Q2 2023 and held it in 8 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer10 Feb ETF position peaked at $163K in Q3 2025.
  • 54 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Feb ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.